Focused Wealth Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-700
Closed -$10.4K – 416
2023
Q4
$10.4K Hold
700
– – ﹤0.01% 541
2023
Q3
$7.87K Buy
+700
New +$8.13K ﹤0.01% 570
2021
Q4
– Sell
-800
Closed -$26K – 1020
2021
Q3
$26K Hold
800
– – ﹤0.01% 460
2021
Q2
$28K Hold
800
– – ﹤0.01% 456
2021
Q1
$24K Hold
800
– – ﹤0.01% 476
2020
Q4
$25K Hold
800
– – ﹤0.01% 428
2020
Q3
$22K Hold
800
– – ﹤0.01% 398
2020
Q2
$17K Hold
800
– – ﹤0.01% 429
2020
Q1
$18K Sell
800
-200
-20% -$5.48K 0.01% 386
2019
Q4
$29K Hold
1,000
– – 0.01% 361
2019
Q3
$27K Hold
1,000
– – 0.01% 354
2019
Q2
$34K Hold
1,000
– – 0.01% 357
2019
Q1
$32K Hold
1,000
– – 0.01% 327
2018
Q4
$32K Buy
+1,000
New +$32.7K 0.01% 335

Other funds holding ELAN

Focused Wealth Management's ELAN Position: Q1 2024 in Review

Focused Wealth Management sold out of Elanco Animal Health (ELAN) in Q1 2024, closing a stake of 700 shares — an estimated $10.4K sold.

Focused Wealth Management first reported a position in ELAN in Q4 2018 and held it in 14 quarters. The position peaked at $34K in Q2 2019. 374 funds tracked by Wall St. Rank hold ELAN as of Q1 2024.

  • Focused Wealth Management reported no remaining Elanco Animal Health position as of Q1 2024 after selling out during the quarter.
  • Focused Wealth Management sold 700 Elanco Animal Health shares in Q1 2024, an estimated $10.4K.
  • Focused Wealth Management first reported a position in Elanco Animal Health in Q4 2018 and held it in 14 quarters.
  • Focused Wealth Management's Elanco Animal Health position peaked at $34K in Q2 2019.
  • 374 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2024.

Based on Focused Wealth Management's 13F filing for Q1 2024, filed 8 May 2024.